ascopubs.org
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women | JCO Oncology Practice
PurposeExcess weight is a key modifiable risk factor for breast cancer. Glucagon-like peptide-1
receptor agonists (GLP-1) promote weight loss and improve metabolic health, but their
effect on breast c...